Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ChiCTR2000040449Phase 4Not yet recruiting
Phase 4, open-label trial of yuye jiedu granules in influenza (2 arms), sponsored by First Teaching Hospital of Tianjin University of Traditional Chinese Medicine. Primary endpoints: Clinical recovery rate and TCM syndrome curative effect (effective rate). Planned start May 2020; status: not yet recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ChiCTR2000040449.